Ventyx Biosciences Inc (NASDAQ:VTYX) price on current trading day, rose 9.34% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.00.
A look at the stock’s price movement, the close in the last trading session was $0.91, moving within a range at $0.8582 and $1.01. The beta value (5-Year monthly) was 0.749. Turning to its 52-week performance, $5.66 and $0.78 were the 52-week high and 52-week low respectively. Overall, VTYX moved -30.07% over the past month.
Ventyx Biosciences Inc’s market cap currently stands at around $71.13 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-26.
Turning to the stock’s technical picture we see that short term indicators suggest on average that VTYX is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
8 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 7 recommend VTYX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
VTYX’s current price about -16.14% and -31.80% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 33.37, while 7-day volatility ratio is 15.24% and 8.57% in the 30-day chart. Further, Ventyx Biosciences Inc (VTYX) has a beta value of 0.89, and an average true range (ATR) of 0.11. Analysts have given the company’s stock an average 52-week price target of $45, forecast between a low of $6 and high of $60. Looking at the price targets, the low is -500.0% off current price level while to achieve the yearly target high, price needs to move -5900.0%. Nonetheless, investors will most likely welcome a -4400.0% jump to $45 which is the analysts’ median price.
If we refocus on Ventyx Biosciences Inc (NASDAQ:VTYX), historical trading data shows that trading volumes averaged 1.59 over the past 10 days and 1.20 million over the past 3 months. The company’s latest data on shares outstanding shows there are 71.13 million shares.
The 12.13% of Ventyx Biosciences Inc’s shares are in the hands of company insiders while institutional holders own 78.57% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 6.91 million on 2025-03-14, giving us a short ratio of 8.76. The data shows that as of 2025-03-14 short interest in Ventyx Biosciences Inc (VTYX) stood at 1135.9999 of shares outstanding, with shares short rising to 6.62 million registered in 2025-02-14. Current price change has pushed the stock -54.34% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the VTYX stock continues to rise going into the next quarter.
